Results 221 to 230 of about 44,419 (235)

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

Genetics in Medicine, 2022
Christoph Engel, MIGUEL De La Hoya, Paolo Peterlongo   +2 more
exaly  

Oestrogen‐mediated phosphorylation and stabilization of BRCA2 protein in breast

Journal of Pathology, 2009
J T Holt
exaly  

APRIN is a cell cycle specific BRCA2‐interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer

EMBO Journal, 2012
Radost Vatcheva, Rachael Natrajan, Jorge S Reis-Filho   +2 more
exaly  

DSS1 and ssDNA regulate oligomerization of BRCA2

Nucleic Acids Research, 2020
Fei Guo, Wolf-Dietrich Heyer, Jie Liu
exaly  

Determination of BRCA2 oncosuppressor protein expression in human mammary cells by affinity perfusion high-performance chromatography

Journal of Proteomics, 2001
Jean-Claude Maurizis, Dominique Bernard-Gallon, Y J Bignon   +2 more
exaly  

Conformational flexibility and oligomerization of BRCA2 regions induced by RAD51 interaction

Nucleic Acids Research, 2020
Arshdeep Sidhu, Humberto Sanchez, Dejan Ristic   +2 more
exaly  

Architectural plasticity of human BRCA2–RAD51 complexes in DNA break repair

Nucleic Acids Research, 2017
Humberto Sanchez, Maarten W Paul, Joyce H G Lebbink   +2 more
exaly  

DSS1 is required for the stability of BRCA2

Oncogene, 2005
David E Wazer, V Band, Qingshen Gao
exaly  

Inhibition of breast and brain cancer cell growth by BCCIPα, an evolutionarily conserved nuclear protein that interacts with BRCA2

Oncogene, 2001
Jingmei Liu, Zhiyuan Shen, Shen Zhiyuan   +2 more
exaly  

GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes

Cancers, 2019
Laura Caleca, Mara Colombo, Thomas Van Overeem Hansen   +2 more
exaly